• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. NUROLON NYLON SUTURE UNKNOWN PRODUCT; SUTURE, NON ABSORBABLE, SYNTHETIC, POLYAMIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. NUROLON NYLON SUTURE UNKNOWN PRODUCT; SUTURE, NON ABSORBABLE, SYNTHETIC, POLYAMIDE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Post Operative Wound Infection (2446); Not Applicable (3189)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.Attempts are being made to obtain the following information.If further details are received at the later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Does the surgeon believe that ethicon products involved caused and/or contributed to the post-operative complications described in the article? does the surgeon believe there was any deficiency with the ethicon products used in this procedure? citation: laryngoscope 122: november 2012; doi: 10.1002/lary.23524.(b)(4).
 
Event Description
It was reported via journal article: title: "retrosigmoid approach to cerebellopontine angle tumor resection: surgical modifications." author(s): selena e.Heman-ackah, md, mba, maura k.Cosetti, md, sachin gupta, md, john g.Golfinos, md, j.Thomas roland, jr., md.Citation: laryngoscope 122: november 2012; doi: 10.1002/lary.23524.This retrospective review aimed to present surgical modifications to the standard retrosigmoid approach that eliminate the need for cerebellar retraction for visualization of the cpa and utilized only native bone for reconstruction of the operative defect and describe the complication rates in association with this approach.Between sep2000 and dec2010, 197 patients (n=96 male and n=101 female) underwent retrosigmoid approach to cerebellopontine angle tumor resection.In the procedure, 4.0 nurolon suture was place through the anterior dura of the incision and secured to a previously created hole in the cortical mastoid bone to retract the dura and the sigmoid sinus anteriorly.Complication included wound infection (n=7) which was treated by removal of bone flap (n=5) and hardware, and conservative treatment (n=2).The use of autologous material in reconstruction may assist in the prevention of postoperative wound infection.The low rate of headache may be attributed to the replacement of the craniotomy bone plate at the conclusion of the procedure as well as a decrease in cerebellar edema secondary to a lack of retractor use in the above described approach.Csf leak is a commonly encountered complication of cpa surgery via the retrosigmoid approach.Csf leaks likely resulted from a communication between the intracranial cells in the region of the iac drill-out and the extracranial mastoid air cells.Perimeatal cells may communicate with air cell tracts in the petrous apex, peritubal region, perilabyrinthine region, or retrofascia region.Cerebellar dysfunction secondary to cerebellar injury intraoperatively is a well-documented potential complication of the retrosigmoid approach and may partially be attributed to excessive cerebellar retraction intraoperatively.This approach is a safe and effective modification of the traditional retrosigmoid approach, with a low rate of postoperative complication, and facilitated intraoperative exposure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NUROLON NYLON SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, NON ABSORBABLE, SYNTHETIC, POLYAMIDE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key7999583
MDR Text Key124827390
Report Number2210968-2018-76726
Device Sequence Number1
Product Code GAR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K946173
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 10/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/24/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-